General Counsel/Secretary of Oncternal Therapeutics, Inc. (NASDAQ:ONCT), Leavitt Chase C., buys 1,500 shares worth $8,175

According to Oncternal Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 15 06:00 PM, company General Counsel/Secretary, Leavitt Chase C. disclosed buying 1,500 shares at a cost of $5.45. At the time of this transaction (Jun 11), this trade was worth $8,175 in total. As of Jun 11, Leavitt Chase C. now owns 1,500 shares in total worth about $7,950.0.

For the last few recent trades made by Oncternal Therapeutics, Inc. (NASDAQ:ONCT) General Counsel/Secretary, Leavitt Chase C., we have the following information:

    Posted by on Wednesday June 16 2021, 10:23 AM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

    Comments are closed

    Featured Press Releases

    Log in